Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

4 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 3

3(60.0%)

Phase 4

1(20.0%)

N/A

1(20.0%)

5Total

Phase 3(3)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06944158Recruiting

Antimicrobial Resistance (AMR) Study

Role: lead

NCT06576154Phase 3Recruiting

The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias in High-Risk Patients

Role: lead

NCT06396507Phase 3Completed

Sulfur vs. Different Regimes of Permethrin for Scabies

Role: collaborator

NCT06150144Phase 3Unknown

The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma

Role: lead

NCT05267860Not ApplicableCompleted

The Efficacy and Safety of Using Prophylactic Abdominal Drainage After Cholecystectomy

Role: lead

NCT05340400Completed

The Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults

Role: lead

NCT05227911Completed

Incidental Findings in Abdominal Surgery

Role: lead

NCT05173584Phase 4Unknown

Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.

Role: lead

All 8 trials loaded